Pompe Program Update May 2007

by | Jul 18, 2016 | News

Pompe Program Update May 2007 There are two studies to further evaluate Myozyme® (alglucosidase alfa) that will be conducted as part of Genzyme’s postmarketing commitments (PMC) to the FDA. A postmarketing commitment is an agreement between a regulatory agency and a...

Genzyme Update on the LOTS Trial- January 2007

by | Jul 18, 2016 | News

In an effort to complete the AGLU02704 study (Late-Onset Treatment Study, LOTS) as responsibly as possible, Genzyme has amended the study protocol to incorporate the use of an adaptive design. Genzyme utilized this method to help ensure a conclusive trial outcome in...